This brief compares the prices paid by private insurers for hospital care to increases in Medicare payment using data from the Bureau of Labor Statistics (BLS) Producer Price Index (PPI), finding that hospital prices have risen much faster for private insurance than Medicare since 2019.
Organizations that can generate and apply high-quality, clinically grounded evidence will be better positioned to close the gap between what is proven in trials and what is achieved in practice. The post Why Real-World Evidence Is Becoming the Missing Link Between Innovation and Patient Care in Oncology appeared first on MedCity News.
The success of Pluvicto has created a new challenge in prostate cancer, one the field has not yet fully named or defined. The post What Comes After Pluvicto? A New and Distinct Prostate Cancer Patient Subpopulation Is Taking Shape appeared first on MedCity News.
Cost management strategies need to focus on simplifying the system, doing away with the outdated processes that inflate costs, and building and deploying tools that allow organizations to control their spending. The post Healthcare Doesn’t Need More Companies Managing Unnecessary Costs – It Needs a System Designed to Eliminate Them appeared first on MedCity News.
In the 39 states that are adopting or may adopt the high unemployment hardship exception, about 1.4 million or 7.5% of Medicaid expansion enrollees live in one of the 133 counties that currently meet the high-unemployment criteria.
Overwhelmed by the demands of caregiving, Quette dialed 911 when she found her teenage son downstairs in their kitchen struggling to breathe. He had rolled his wheelchair to the oven to keep himself warm as he tried to regulate his temperature, she recalled, and was drenched in sweat from an apparent infection. In that moment,…
In 1996, Guinea-Bissau seemed like an ideal research post for budding pediatrician Lone Graff Stensballe. Her supervisor, a fellow Dane named Peter Aaby, had spent nearly two decades collecting data on 100,000 people living in the mud brick homes of the West African country’s capital. Aaby and his partner, Christine Stabell Benn, believed that the…
President Donald Trump earlier this year bought as much as $680,000 in stock of Eli Lilly, the maker of blockbuster obesity drugs, as the agencies he oversees undertook an agenda that largely benefited the company. On May 14, the federal government released ethics disclosures revealing a list of stock and bond trades made on Trump’s…
By OWEN TRIPP For decades, quality in healthcare has been defined on industry terms — not people’s terms. New technology and innovative health plan designs are finally changing that. People know quality when they see it, and they are definitely not seeing it in healthcare. Fifty-six percent of Americans rate the quality of care as…
Duracyte’s implants employ cells engineered to produce therapeutic protein, bypassing the complexities of traditional biologics manufacturing. The startup’s marriage of biotechnology with electronics comes with on-board sensors that enable clinicians to monitor and control an implant’s drug production process. The post This Startup Aims to Upend Biologic Drug Production With Implantable ‘Cell Factories’ appeared first…